ACE Inhibition and Novel Cardiovascular Risk Factors
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
0
Participant gender:
All
Summary
To determine the effects of an angiotensin converting enzyme inhibitor (ACE inhibitor),
fosinopril, on multiple blood markers in 286 adults at high risk for cardiovascular disease.